Mr. Speaker, what we are looking for is leadership on the issue. I have mentioned the need to be compassionate in that process, but we are looking at 40 countries in the world where this particular drug, Rituxan, that I am mentioning by name, has been approved. We are bogged down in a regulatory process that is denying patients that drug.
We are looking for international leadership to allow us to exchange information with other jurisdictions. Does the minister have a plan to share international information to avoid the cost of duplication in bringing these drugs to market?